Ultralong-segment Barrett's Esophagus: Towards a Capsule-sponge Surveillance Strategy
- Sponsor
- Erasmus Medical Center
- Study ID
- NCT06720636
- Status
- Recruiting
Conditions
- Barrett Esophagus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- EndoSign — DEVICEThe EndoSign cell collection device is a non-endoscopic capsule sponge device used to collect pan-esophageal samples. The Endosign procedure consists of an expandable, spherical mesh, which is attached to a string and contained within a soluble capsule. Seven minutes after swallowing (once the capsule has dissolved), the spherical mesh, which measures around 3cm in diameter is retrieved by pulling on the string. Upon retrieval the capsule-sponge scrapes against the surface of the top of the stomach and esophagus and collects epithelial cells. The capsule-sponge sample is then placed into a preservative fluid and the specimen is processed for molecular tests.
Study Details
The purpose of this study is to evaluate the Endosign capsule sponge test as a novel surveillance method in patients with an ultralong-segment Barrett's esophagus.
Key Dates
- First listed
- Dec 6, 2024
- Start date
- Feb 3, 2025
- Status verified
- Aug 2025
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 137 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Study groupSubjects will receive the EndoSign test prior to their scheduled clinically indicated upper endoscopy by an expert endoscopist, per routine standard of care. Additional biopsies will be taken and 10cc of blood will be collected from the cannula used for sedation. Subjects will also receive three questionnaires regarding baseline characteristics, gastrointestinal symptoms and acceptability.
Primary Outcome Measure
Concordance between EndoSign and upper endoscopy to detect dysplasia and/or esophageal adenocarcinoma [ Time Frame: 3 years ]
Central Contacts
- Anne-Elise C de Groen, MSc003110 703 16 93
- Judith Honing, MSc, PhD003110 703 16 93
Related Studies
- Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's EsophagusRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- The Johns Hopkins Heartburn Center RegistryEnrolling By Invitation · Johns Hopkins University · Orange, California
- Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaRecruiting · Mayo Clinic · Austin, Minnesota
- EsophaCap for the Detection of Early Esophageal CarcinomaRecruiting · Johns Hopkins University · Baltimore, Maryland